{"pageContent": "Purpose: To describe outcomes of men with unfavorable (high-tier) intermediate risk prostate cancer (H-IR) treated with low-dose-rate (LDR) brachytherapy, with or without 6 months of androgen deprivation therapy (ADT).", "metaData": {"source": "Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset\nhttps://pubmed.ncbi.nlm.nih.gov/26801762/"}}